-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EZFFLi4MQ5JO0dJ6c1yuvOABU7CVEL7/lY4+jXzVIFxM/kFav6P+Dmqbv/4aXC1l We8Jqhw2vFDcs8xkMA9wkA== 0000950133-08-002191.txt : 20080606 0000950133-08-002191.hdr.sgml : 20080606 20080606163233 ACCESSION NUMBER: 0000950133-08-002191 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080605 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080606 DATE AS OF CHANGE: 20080606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENTREMED INC CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 08886070 BUSINESS ADDRESS: STREET 1: 9640 MEDICAL CNTR DR STREET 2: STE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3012179858 MAIL ADDRESS: STREET 1: 9640 MEDICAL CNTR SR STREET 2: STE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 8-K 1 w60220e8vk.htm 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 5, 2008
ENTREMED, INC.
(Exact Name of Registrant as Specified in its Charter)
         
DELAWARE   0-20713   58-1959440
         
(State or other jurisdiction of   (Commission File Number)   (IRS Employer Identification
incorporation or organization)       No.)
9640 Medical Center Drive
Rockville, Maryland
 
(Address of principal executive offices)
20850
 
(Zip Code)
(240) 864-2600
 
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain  Officers; Compensatory Arrangements of Certain Officers.
     On June 5, 2008, EntreMed, Inc. (the “Company”) and Dr. Carolyn Sidor, the Company’s Chief Medical Officer, amended Dr. Sidor’s employment agreement to provide for a change in her work location from the Company’s office in Rockville, Maryland to the Company’s office in Durham, North Carolina, where the Company manages its clinical operations. In connection with the change in work location, Dr. Sidor was not designated an executive officer for the 2008-2009 term but will continue to serve as the Company’s Chief Medical Officer with no change in responsibilities and duties. The amendment is effective immediately.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
 
  ENTREMED, INC.    
 
        
 
  /s/ Cynthia Wong Hu    
 
       
 
  Cynthia Wong Hu    
 
  Vice-President, General Counsel & Corporate Secretary    
Date: June 6, 2008

 

-----END PRIVACY-ENHANCED MESSAGE-----